Skip to main content

Foreign exchange

US Wrap: Is Barclays note flood sign of rebound?

Barclays Bank has launched 31 new reverse convertible notes into the US market, one of the most compelling signs yet of an upturn in issuance. By far the most prevalent theme was energy, which represented the underlying for 10 of the new notes. Financial…

New FASB standards threaten off-balance-sheet vehicles

The US Financial Accounting Standards Board (FASB) has completed new rules on off-balance-sheet holdings that will compel US companies to consolidate on balance sheet billions of dollars of assets previously kept in special-purpose entities (SPEs).

iShares acquires Mexico’s Naftrac ETF

iShares has acquired the largest and first exchange-traded fund (ETF) in Mexico and Latin America. The Naftrac ETF follows the performance of the IPC (Indice de Precios y Cotizaciones), which is a Mexican stock market index.

Morgan Stanley fined over $120m mismark

The UK Financial Services Authority has fined Morgan Stanley £1.4 million for failing to supervise one of its prop traders, allowing him to mismark a portfolio of illiquid credit products by $120 million last year.

Hess leaves Goldman Sachs and returns to Citi

Dirk Hess has joined Citi as a director in the EMEA retail structured products business. Hess will split his time between London and Frankfurt, and be responsible for working across the sales, marketing and new issuance teams to build out Citi's cross…

Downturn changes oil & gas risk landscape

The oil & gas sector has been severely impacted by the global economic downturn, with new risks for the industry emerging that threaten the near-term survival and prospects of companies, according to a report from accounting firm Ernst & Young.

Ambac makes $1.539bn derivatives gain

Ambac reported a massive $1.539 billion mark-to-market gain on credit default swaps (CDSs) in the first quarter – an upswing largely due to its own deteriorating financial condition.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here